BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34461485)

  • 21. Long-term survival and prognostic factors in patients with metastatic gastric cancers treated with chemotherapy in the Japan Clinical Oncology Group (JCOG) study.
    Yoshida M; Ohtsu A; Boku N; Miyata Y; Shirao K; Shimada Y; Hyodo I; Koizumi W; Kurihara M; Yoshida S; Yamamoto S
    Jpn J Clin Oncol; 2004 Nov; 34(11):654-9. PubMed ID: 15613554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic role of body composition parameters in gastric/gastroesophageal junction cancer patients from the EXPAND trial.
    Hacker UT; Hasenclever D; Linder N; Stocker G; Chung HC; Kang YK; Moehler M; Busse H; Lordick F
    J Cachexia Sarcopenia Muscle; 2020 Feb; 11(1):135-144. PubMed ID: 31464089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of neutrophil-to-lymphocyte ratio in advanced oesophago-gastric cancer: exploratory analysis of the REAL-2 trial.
    Grenader T; Waddell T; Peckitt C; Oates J; Starling N; Cunningham D; Bridgewater J
    Ann Oncol; 2016 Apr; 27(4):687-92. PubMed ID: 26787231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastric cancer with initial bone metastasis: a distinct group of diseases with poor prognosis.
    Kim YJ; Kim SH; Kim JW; Lee JO; Kim JH; Bang SM; Lee JS; Lee KW
    Eur J Cancer; 2014 Nov; 50(16):2810-21. PubMed ID: 25201165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of pretreatment inflammatory biomarkers in advanced lung adenocarcinoma patients receiving first-line pemetrexed/platinum doublet.
    Xiong Y; Zhao N; Zheng Y; Wang J; Wei F; Ren X
    Tumour Biol; 2017 Jun; 39(6):1010428317701639. PubMed ID: 28618954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prognostic model in patients treated for metastatic gastric cancer with second-line chemotherapy.
    Kanagavel D; Pokataev IA; Fedyanin MY; Tryakin AA; Bazin IS; Narimanov MN; Yakovleva ES; Garin AM; Tjulandin SA
    Ann Oncol; 2010 Sep; 21(9):1779-1785. PubMed ID: 20150573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prealbumin and lymphocyte-based prognostic score, a new tool for predicting long-term survival after curative resection of stage II/III gastric cancer.
    Shen Q; Liu W; Quan H; Pan S; Li S; Zhou T; Ouyang Y; Xiao H
    Br J Nutr; 2018 Dec; 120(12):1359-1369. PubMed ID: 30370885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical study on surgical method and prognosis in diffuse-type advanced gastric cancer].
    Yang J; Li L; Zhang G; Zhou H; Yu Z; Jiao Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 41(2):151-7. PubMed ID: 26932212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapy.
    Jin H; Zhang G; Liu X; Liu X; Chen C; Yu H; Huang X; Zhang Q; Yu J
    World J Surg Oncol; 2013 May; 11():112. PubMed ID: 23705622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prognostic model based on lymph node metastatic ratio for predicting survival outcome in gastric cancer patients with N3b subclassification.
    Hung YS; Chang SC; Liu KH; Hung CY; Kuo YC; Tsai CY; Hsu JT; Yeh TS; Chen JS; Chou WC
    Asian J Surg; 2019 Jan; 42(1):85-92. PubMed ID: 29248301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Hematologic and Other Prognostic Markers in Metastatic Colorectal Cancer.
    Mercier J; Voutsadakis IA
    J Gastrointest Cancer; 2019 Sep; 50(3):493-506. PubMed ID: 29704170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutrophil count and the inflammation-based glasgow prognostic score predict survival in patients with advanced gastric cancer receiving first-line chemotherapy.
    Li QQ; Lu ZH; Yang L; Lu M; Zhang XT; Li J; Zhou J; Wang XC; Gong JF; Gao J; Li J; Li Y; Shen L
    Asian Pac J Cancer Prev; 2014; 15(2):945-50. PubMed ID: 24568523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevation of Neutrophil-to-Lymphocyte Ratio before First-Line Chemotherapy Predicts a Poor Prognosis for Second-Line Chemotherapy in Gastric Cancer.
    Inoue D; Sekiguchi S; Yamagata W; Maeda G; Yamada D; Fujiwara S; Itou S; Kurihara M; Hijioka Y; Shimoji K; Fujiki J; Nakazono A; Horike H; Yoshioka A; Ogura Y; Hatao F; Imamura K; Namiki S
    Oncology; 2019; 96(3):140-146. PubMed ID: 30368510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Second-line chemotherapy for patients with advanced gastric cancer: who may benefit?
    Catalano V; Graziano F; Santini D; D'Emidio S; Baldelli AM; Rossi D; Vincenzi B; Giordani P; Alessandroni P; Testa E; Tonini G; Catalano G
    Br J Cancer; 2008 Nov; 99(9):1402-7. PubMed ID: 18971936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prognostic value of international prognostic index, revised international prognostic index, enhanced international prognostic index and Grupo Español de Linfomas/trasplante autólogo de médula ósea-international prognostic index for diffuse large B-cell lymphoma].
    Feng YX; Su LP
    Zhonghua Zhong Liu Za Zhi; 2020 Nov; 42(11):949-954. PubMed ID: 33256307
    [No Abstract]   [Full Text] [Related]  

  • 36. The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics.
    Wang J; Liu Y; Mi X; Shao M; Liu L
    Ann Palliat Med; 2020 May; 9(3):967-978. PubMed ID: 32389020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic model to predict survival following first-line chemotherapy in patients with metastatic gastric adenocarcinoma.
    Lee J; Lim T; Uhm JE; Park KW; Park SH; Lee SC; Park JO; Park YS; Lim HY; Sohn TS; Noh JH; Heo JS; Park CK; Kim S; Kang WK
    Ann Oncol; 2007 May; 18(5):886-91. PubMed ID: 17298958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.
    Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST
    Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new prognostic index for overall survival in malignant pleural mesothelioma: the rPHS (regimen, PS, histology or stage) index.
    Kataoka Y; Yamamoto Y; Otsuki T; Shinomiya M; Terada T; Fukuma S; Yamazaki S; Hirabayashi M; Nakano T; Fukuhara S
    Jpn J Clin Oncol; 2015 Jun; 45(6):562-8. PubMed ID: 25838292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The characteristics and prognostic value of signet ring cell histology in gastric cancer: A retrospective cohort study of 2199 consecutive patients.
    Lu M; Yang Z; Feng Q; Yu M; Zhang Y; Mao C; Shen L; Tang J
    Medicine (Baltimore); 2016 Jul; 95(27):e4052. PubMed ID: 27399088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.